Zentiva Competitors and Similar CompaniesClear all

Zentiva's competitors and similar companies include Grunenthal, Biocodex, Swedish Orphan Biovitrum and Ipsen.
Zentiva
Zentiva
Zentiva is a company that develops and manufactures generic medicines.
Grunenthal
Grunenthal
Grunenthal is a pharmaceutical company.
Biocodex
Biocodex
Biocodex is a pharmaceutical company that specializes in the development of drugs.
Swedish Orphan Biovitrum
Swedish Orphan Biovitrum
Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care.
Ipsen
Ipsen
Ipsen is a biopharmaceutical company.
Founding Date
Founding Date
2003
Founding Date
1946
Founding Date
1953
Founding Date
2010
Founding Date
1929
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
CZ HQ
Tallinn, EE
Paris, FR
Mumbai, IN
Milano, IT
Milano, IT
Rīga, LV
see more
Locations
Aachen, DE HQ
Brunn Am Gebirge, AT
Zaventem, BE
Santiago, CL
Apartadó, CO
København, DK
see more
Locations
Gentilly, FR HQ
Anderlecht, BE
Espoo, FI
Ciudad De México, MX
Nouasseur, MA
Warszawa, PL
Lisboa, PT
see more
Locations
Solna, SE HQ
Sydney, AU
Wien, AT
Zaventem, BE
Sofia, BG
Oakville, CA
Beijng, CN
see more
Locations
Boulogne-Billancourt, FR HQ
Algiers, DZ
South Yarra, AU
Wien, AT
Merelbeke, BE
São Paulo, BR
Mississauga, CA
see more
Employees
Employees
3,4721% increase
Employees
4,590
Employees
1,5741% increase
Employees
1,895
Employees
5,358
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
11.1 b
Valuation ($)
10.2 b

Financial

Revenue (est.)
Revenue (est.)
Kč2.3b (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
€310m (FY, 2018)
Revenue (est.)
kr28.2b (FY, 2025)
Revenue (est.)
€3.7b (FY, 2025)
Cost of goods
Cost of goods
Kč807.2m (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
kr6.2b (FY, 2025)
Cost of goods
€659.1m (FY, 2025)
Gross profit
Gross profit
Kč1.5b (FY, 2021)
Gross profit
N/A
Gross profit
N/A
Gross profit
kr22b (FY, 2025)
Gross profit
€3.3b (FY, 2025)
Net income
Net income
(Kč831.2m) (FY, 2021)
Net income
N/A
Net income
N/A
Net income
kr476m (FY, 2025)
Net income
€445.1m (FY, 2025)

Operating

Countries
Countries
35 (Apr, 2023)
Countries
N/A
Countries
120 (Dec, 2019)
Countries
N/A
Countries
N/A
For sources of this data, please see the company profile

View Company Profiles

Grunenthal
HQ
Aachen, DE
Employees
4,590

Grunenthal is a pharmaceutical company.

View company
Biocodex
HQ
Gentilly, FR
Employees
1,574↑ 1% increase

Biocodex is a pharmaceutical company that specializes in the development of drugs.

View company
Swedish Orphan Biovitrum
HQ
Solna, SE
Employees
1,895

Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care.

View company
Ipsen
HQ
Boulogne-Billancourt, FR
Employees
5,358

Ipsen is a biopharmaceutical company.

View company